Consun Pharmaceutical Group Ltd

01681

Company Profile

  • Business description

    Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

  • Contact

    71, Dongpeng Avenue
    Eastern section
    Guangzhou Economic and Technological Development
    Guangzhou
    CHN

    T: +86 2082264529

    https://www.chinaconsun.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    3,073

Stocks News & Analysis

stocks

This might be the best core stock bargain in the US market today

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.
stocks

Data center demand drives strong earnings outlook for SGM

Sims guides huge earnings upgrade as data center metals demand spikes.
stocks

Chart of the Week: AI proving a threat to company moats

The latest insights on AI from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,628.3034.80-0.40%
CAC 407,820.9413.070.17%
DAX 4022,860.4920.930.09%
Dow JONES (US)46,021.43203.72-0.44%
FTSE 10010,082.1418.640.19%
HKSE25,277.32223.26-0.88%
NASDAQ22,090.6961.73-0.28%
Nikkei 22553,372.531,866.87-3.38%
NZX 50 Index12,989.9961.62-0.47%
S&P 5006,606.490.000.00%
S&P/ASX 2008,428.4043.90-0.52%
SSE Composite Index3,957.0549.50-1.24%

Market Movers